Selective inhibition of PED protein expression sensitizes B‐cell chronic lymphocytic leukaemia cells to TRAIL‐induced apoptosis
Open Access
- 27 December 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (6) , 1215-1222
Abstract
B‐cell chronic lymphocytic leukaemia (B‐CLL) cells fail to undergo apoptosis. The mechanism underlying this resistance to cell death is still largely unknown. Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) effectively kills tumour cells but not normal cells, and thus represents an attractive tool for the treatment of cancer. Unfortunately, lymphocytes from B‐CLL patients are resistant to TRAIL‐mediated apoptosis. Thus, we aimed to study the involvement of PED, a DED‐family member with a broad antiapoptotic action, in this resistance. We demonstrate that B lymphocytes obtained from patients with B‐CLL express high levels of PED. Treatment of B‐CLL cells with specific PED antisense oligonucleotides, a protein synthesis inhibitor or HDAC inhibitors, induced a significant downregulation of PED and sensitized these cells to TRAIL‐induced cell death. These findings suggest a direct involvement of PED in resistance to TRAIL‐induced apoptosis in B‐CLL. It also identifies this DED‐family member as a potential therapeutic target for this form of leukaemia.Keywords
This publication has 29 references indexed in Scilit:
- Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cellsJournal of Cellular Physiology, 2005
- Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotidesBlood, 2005
- Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignanciesCell Death & Differentiation, 2004
- Rapamycin inhibits doxorubicin-induced NF-κB/Rel nuclear activity and enhances the apoptosis of melanoma cellsEuropean Journal of Cancer, 2004
- Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIPCell Death & Differentiation, 2004
- Histone deacetylase inhibitors in cancer therapyCancer Cell, 2003
- Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma CellsJournal of Biological Chemistry, 2002
- EFFECT OF TWO-ROUND FICOLL-HYPAQUE DENSITY GRADIENT CENTRIFUGATION ON LYMPHOCYTE SUBSETS AND NATURAL KILLER ACTIVITY OF UMBILICAL CORD BLOOD MONONUCLEAR CELLSPediatric Hematology and Oncology, 2001
- PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosisOncogene, 1999
- B cells and their fate in health and diseaseImmunology Today, 1996